Strides Pharma Science Limited (NSE:STAR)
984.00
-9.00 (-0.91%)
Aug 21, 2026, 3:29 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 90.9 billion as of August 21, 2026. Its market cap has increased by 12.44% in one year.
Market Cap
90.90B
Enterprise Value
106.85B
Revenue
50.04B
Ranking
n/a
PE Ratio
14.82
Stock Price
984.00
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 90.90B, an increase of 1,112.99%. That is a compound annual growth rate of 9.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 90.90B | 9.54% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 184.05B |
| Cohance Lifesciences | 181.93B |
| Alivus Life Sciences | 165.81B |
| Alembic Pharmaceuticals | 160.02B |
| NATCO Pharma | 157.17B |
| Sudeep Pharma | 125.12B |
| Akums Drugs and Pharmaceuticals | 115.27B |
| Aarti Pharmalabs | 74.05B |